These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 20799004)
1. Genomic profiles in B cell lymphoma. Seto M Int J Hematol; 2010 Sep; 92(2):238-45. PubMed ID: 20799004 [TBL] [Abstract][Full Text] [Related]
2. [Analysis of genomic copy number alterations of malignant lymphomas and its application for diagnosis]. Tagawa H Gan To Kagaku Ryoho; 2007 Jul; 34(7):975-82. PubMed ID: 17637530 [TBL] [Abstract][Full Text] [Related]
3. Comparative genome profiling across subtypes of low-grade B-cell lymphoma identifies type-specific and common aberrations that target genes with a role in B-cell neoplasia. Ferreira BI; García JF; Suela J; Mollejo M; Camacho FI; Carro A; Montes S; Piris MA; Cigudosa JC Haematologica; 2008 May; 93(5):670-9. PubMed ID: 18367492 [TBL] [Abstract][Full Text] [Related]
4. [Molecular abnormalities in lymphomas]. Delsol G Bull Cancer; 2010 Nov; 97(11):1347-64. PubMed ID: 21084243 [TBL] [Abstract][Full Text] [Related]
5. Diversity of genome profiles in malignant lymphoma. Seto M; Honma K; Nakagawa M Cancer Sci; 2010 Mar; 101(3):573-8. PubMed ID: 20070305 [TBL] [Abstract][Full Text] [Related]
6. Clinical implication of genome-wide profiling in diffuse large B-cell lymphoma and other subtypes of B-cell lymphoma. Iqbal J; Joshi S; Patel KN; Javed SI; Kucuk C; Aabida A; d'Amore F; Fu K Indian J Cancer; 2007; 44(2):72-86. PubMed ID: 17938484 [TBL] [Abstract][Full Text] [Related]
7. New insights into the biology and origin of mature aggressive B-cell lymphomas by combined epigenomic, genomic, and transcriptional profiling. Martín-Subero JI; Kreuz M; Bibikova M; Bentink S; Ammerpohl O; Wickham-Garcia E; Rosolowski M; Richter J; Lopez-Serra L; Ballestar E; Berger H; Agirre X; Bernd HW; Calvanese V; Cogliatti SB; Drexler HG; Fan JB; Fraga MF; Hansmann ML; Hummel M; Klapper W; Korn B; Küppers R; Macleod RA; Möller P; Ott G; Pott C; Prosper F; Rosenwald A; Schwaenen C; Schübeler D; Seifert M; Stürzenhofecker B; Weber M; Wessendorf S; Loeffler M; Trümper L; Stein H; Spang R; Esteller M; Barker D; Hasenclever D; Siebert R; Blood; 2009 Mar; 113(11):2488-97. PubMed ID: 19075189 [TBL] [Abstract][Full Text] [Related]
11. [Molecular biology of malignant lymphomas for non-specialists]. Novak U Ther Umsch; 2010 Oct; 67(10):501-4. PubMed ID: 20886455 [TBL] [Abstract][Full Text] [Related]
12. Further delineation of chromosomal consensus regions in primary mediastinal B-cell lymphomas: an analysis of 37 tumor samples using high-resolution genomic profiling (array-CGH). Wessendorf S; Barth TF; Viardot A; Mueller A; Kestler HA; Kohlhammer H; Lichter P; Bentz M; Döhner H; Möller P; Schwaenen C Leukemia; 2007 Dec; 21(12):2463-9. PubMed ID: 17728785 [TBL] [Abstract][Full Text] [Related]
13. MALT1 is deregulated by both chromosomal translocation and amplification in B-cell non-Hodgkin lymphoma. Sanchez-Izquierdo D; Buchonnet G; Siebert R; Gascoyne RD; Climent J; Karran L; Marin M; Blesa D; Horsman D; Rosenwald A; Staudt LM; Albertson DG; Du MQ; Ye H; Marynen P; Garcia-Conde J; Pinkel D; Dyer MJ; Martinez-Climent JA Blood; 2003 Jun; 101(11):4539-46. PubMed ID: 12560219 [TBL] [Abstract][Full Text] [Related]
14. Genomic signatures in B-cell lymphoma: How can these improve precision in diagnosis and inform prognosis? Iqbal J; Naushad H; Bi C; Yu J; Bouska A; Rohr J; Chao W; Fu K; Chan WC; Vose JM Blood Rev; 2016 Mar; 30(2):73-88. PubMed ID: 26432520 [TBL] [Abstract][Full Text] [Related]
15. Deregulated expression of HDAC9 in B cells promotes development of lymphoproliferative disease and lymphoma in mice. Gil VS; Bhagat G; Howell L; Zhang J; Kim CH; Stengel S; Vega F; Zelent A; Petrie K Dis Model Mech; 2016 Dec; 9(12):1483-1495. PubMed ID: 27799148 [TBL] [Abstract][Full Text] [Related]
16. FAS death domain deletions and cellular FADD-like interleukin 1beta converting enzyme inhibitory protein (long) overexpression: alternative mechanisms for deregulating the extrinsic apoptotic pathway in diffuse large B-cell lymphoma subtypes. Takahashi H; Feuerhake F; Kutok JL; Monti S; Dal Cin P; Neuberg D; Aster JC; Shipp MA Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3265-71. PubMed ID: 16740746 [TBL] [Abstract][Full Text] [Related]
17. Deregulated PAX-5 transcription from a translocated IgH promoter in marginal zone lymphoma. Morrison AM; Jäger U; Chott A; Schebesta M; Haas OA; Busslinger M Blood; 1998 Nov; 92(10):3865-78. PubMed ID: 9808580 [TBL] [Abstract][Full Text] [Related]
18. B Cell Lymphoma. Meng X; Min Q; Wang JY Adv Exp Med Biol; 2020; 1254():161-181. PubMed ID: 32323276 [TBL] [Abstract][Full Text] [Related]
19. Microarray analysis of B-cell lymphoma cell lines with the t(14;18). Robetorye RS; Bohling SD; Morgan JW; Fillmore GC; Lim MS; Elenitoba-Johnson KS J Mol Diagn; 2002 Aug; 4(3):123-36. PubMed ID: 12169673 [TBL] [Abstract][Full Text] [Related]
20. Novel insights into the disease dynamics of B-cell lymphomas in the Genomics Era. Chan FC; Lim E; Kridel R; Steidl C J Pathol; 2018 Apr; 244(5):598-609. PubMed ID: 29359812 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]